Search Results - "KUZU, Ömer Faruk"

Regulation of the unfolded protein response through ATF4 and FAM129A in prostate cancer by Pällmann, Nora, Livgård, Marte, Tesikova, Martina, Zeynep Nenseth, Hatice, Akkus, Erman, Sikkeland, Jørgen, Jin, Yixin, Koc, Dogukan, Kuzu, Omer Faruk, Pradhan, Manohar, Danielsen, Håvard E., Kahraman, Nermin, Mokhlis, Hamada M., Ozpolat, Bulent, Banerjee, Partha P., Uren, Aykut, Fazli, Ladan, Rennie, Paul S., Jin, Yang, Saatcioglu, Fahri

“…Cancer cells exploit many of the cellular adaptive responses to support their survival needs. One such critical pathway in eukaryotic cells is the unfolded…”
Get full text

Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer by Unal, Bilal, Kuzu, Omer Faruk, Jin, Yang, Osorio, Daniel, Kildal, Wanja, Pradhan, Manohar, Kung, Sonia H. Y., Oo, Htoo Zarni, Daugaard, Mads, Vendelbo, Mikkel, Patterson, John B., Thomsen, Martin Kristian, Kuijjer, Marieke Lydia, Saatcioglu, Fahri

“…Unfolded protein response (UPR) is a central stress response pathway that is hijacked by tumor cells for their survival. Here, we find that IRE1α signaling,…”
Get full text

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling by Sheng, Xia, Nenseth, Hatice Zeynep, Qu, Su, Kuzu, Omer F., Frahnow, Turid, Simon, Lukas, Greene, Stephanie, Zeng, Qingping, Fazli, Ladan, Rennie, Paul S., Mills, Ian G., Danielsen, Håvard, Theis, Fabian, Patterson, John B., Jin, Yang, Saatcioglu, Fahri

“…Activation of endoplasmic reticulum (ER) stress/the unfolded protein response (UPR) has been linked to cancer, but the molecular mechanisms are poorly…”
Get full text

The Role of High Dose Chemotherapy with Autologous Hematopoietic Cell Transplant in Relapsed/Refractory Ovarian Germ Cell Tumors: A Single Center Experience by Topal, Alper, Erturk, Ismail, Koseoglu, Caglar, Dumludag, Aysegul, Kuzu, Ömer Faruk, Durmaz, Pelin, Akdag, Goncagul, Keskin, Gul Sema Yildiran, Karadurmus, Nuri

“…We aimed to investigate response rates, survival analyses and factors affecting survival in patients with relapsed or refractory ovarian germ cell tumours who…”
Get full text

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzaffer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Urul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

“…There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor…”
Get full text

Salvage Treatment for Extragonadal Germ Cell Tumours: High-Dose Chemotherapy and Autologous Stem Cell Transplantation Outcomes—A Single-Centre Experience by Topal, Alper, Erturk, Ismail, Koseoglu, Caglar, Dumludag, Aysegul, Kuzu, Ömer Faruk, Karadurmus, Berkan, Kaplan Tuzun, Esmanur, Atacan, Huseyin, Mammadzada, Nurlan, Yildirim, Gizem, Acar, Ramazan, Karadurmus, Nuri

“…Objective: Extragonadal germ cell tumours have a more unfavourable prognosis than gonadal germ cell tumours. We aimed to evaluate the survival analysis,…”
Get full text

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzafer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Erul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

Get full text

Efficacy of Perioperative FLOT Therapy in Locally Advanced Gastric Cancer and the Associated Prognostic Factors by YILDIRAN KESKİN, Gül Sema, ERTÜRK, İsmail, AYKAN, Musa Barış, ACAR, Ramazan, TOPAL, Alper, DUMLUDAĞ, Ayşegül, KÖSEOĞLU, Çağlar, KUZU, Ömer Faruk, DURMAZ, Pelin, DEDE, İsa, KÖSE, Ahmet Fatih, KARADURMUŞ, Nuri

Get full text

Abstract 7416: GeneSetR: A web server for gene set analysis based on genome-wide Perturb-Seq data by Kuzu, Omer Faruk, Saatcioglu, Fahri

“…Abstract Identification of genotype-phenotype relationships is of utmost importance and a core effort in biology. Recent developments in efficient and precise…”
Get full text

Immunological facets of prostate cancer and the potential of immune checkpoint inhibition in disease management by Hansen, Stian Bakke, Unal, Bilal, Kuzu, Omer Faruk, Saatcioglu, Fahri

Get full text

STAMP2 Expression Mediated by Cytokines Attenuates Their Growth-Limiting Effects in Prostate Cancer Cells by Pihlstrøm, Nicklas, Jin, Yang, Nenseth, Zeynep, Kuzu, Omer F, Saatcioglu, Fahri

“…Inflammatory events and dysregulated cytokine expression are implicated in prostate cancer (PCa), but the underlying molecular mechanisms are poorly understood…”
Get full text

The impact of transfusion burden and comorbidities on the prognosis of patients with myelodysplastic syndromes by Sarici, Ahmet, Ar, Muhlis Cem, Yokus, Osman, Ongoren, Seniz, Ayer, Mesut, Altindal, Sermin, Koker, Hilal Tan, Kuzu, Omer Faruk

“…Early comorbidity detection has been reported to be associated with treatment-related outcomes in several diseases. Two main goals of the present study were to…”
Get full text

Abstract 5362: Targeting IRE1α alleviates the immunosuppressive tumor microenvironment in prostate cancer by Unal, Bilal, Kuzu, Omer Faruk, Jin, Yang, Hurtado, Daniel Camilo, Kuijjer, Marieke Lydia, Daugaard, Mads, Oo, Htoo Zarni, Patterson, John B., Saatcioglu, Fahri

“…Abstract Unfolded protein response (UPR) is a central stress response pathway in normal cells that is hijacked by tumor cells for their survival. However, how…”
Get full text

Evaluation of clinical and prognostic factors for primary gastric diffuse large B-cell lymphoma: Single-center experience by Bardakci, Murat, Esmer, Derya, Hafizoglu, Emre, Karaman, Kemal, Kuzu, Omer, Karakas, Hilal, Gungorer, Bulent, Uncu, Dogan

“…Objective: Primary gastric lymphomas, which make up the vast majority of extranodal non-Hodgkin lymphoma, are rare and the most common subtype is primary…”
Get full text